WEKO3
アイテム
Olanzapine for The Prevention of Nausea and Vomiting Caused by Chemoradiotherapy with High-Dose Cisplatin for Head and Neck Cancer
https://repository.lib.tottori-u.ac.jp/records/7691
https://repository.lib.tottori-u.ac.jp/records/769141a97a15-0a72-49ee-94ba-cf2353907105
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
yam66(2)_208.pdf (1.0 MB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2023-07-18 | |||||
| タイトル | ||||||
| タイトル | Olanzapine for The Prevention of Nausea and Vomiting Caused by Chemoradiotherapy with High-Dose Cisplatin for Head and Neck Cancer | |||||
| 言語 | en | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| キーワード | ||||||
| 主題 | chemoradiotherapy | |||||
| キーワード | ||||||
| 主題 | cisplatin | |||||
| キーワード | ||||||
| 主題 | head and neck cancer | |||||
| キーワード | ||||||
| 主題 | nausea and vomiting | |||||
| キーワード | ||||||
| 主題 | olanzapine | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | chemoradiotherapy | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | cisplatin | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | head and neck cancer | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | nausea and vomiting | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | olanzapine | |||||
| 資源タイプ | ||||||
| 資源タイプ | journal article | |||||
| 著者 |
小山, 哲
× 小山, 哲× Ehara, Hiroaki× Donishi, Ryohei× Morisaki, Tsuyoshi× Taira, Kenkichiro× 福原, 隆宏× 藤原, 和典× Ehara, Hiroaki× Donishi, Ryohei× Morisaki, Tsuyoshi× Taira, Kenkichiro |
|||||
| 著者所属（英） | ||||||
| 言語 | en | |||||
| 値 | Division of Otolaryngology, Head and Neck Surgery, Department of Sensory and Motor Organs, School of Medicine, Faculty of Medicine, Tottori University | |||||
| 著者所属（英） | ||||||
| 言語 | en | |||||
| 値 | Division of Otolaryngology, Head and Neck Surgery, Department of Sensory and Motor Organs, School of Medicine, Faculty of Medicine, Tottori University | |||||
| 著者所属（英） | ||||||
| 言語 | en | |||||
| 値 | Division of Otolaryngology, Head and Neck Surgery, Department of Sensory and Motor Organs, School of Medicine, Faculty of Medicine, Tottori University | |||||
| 著者所属（英） | ||||||
| 言語 | en | |||||
| 値 | Division of Otolaryngology, Head and Neck Surgery, Department of Sensory and Motor Organs, School of Medicine, Faculty of Medicine, Tottori University | |||||
| 著者所属（英） | ||||||
| 言語 | en | |||||
| 値 | Division of Otolaryngology, Head and Neck Surgery, Department of Sensory and Motor Organs, School of Medicine, Faculty of Medicine, Tottori University | |||||
| 著者所属（英） | ||||||
| 言語 | en | |||||
| 値 | Division of Otolaryngology, Head and Neck Surgery, Department of Sensory and Motor Organs, School of Medicine, Faculty of Medicine, Tottori University | |||||
| 著者所属（英） | ||||||
| 言語 | en | |||||
| 値 | Division of Otolaryngology, Head and Neck Surgery, Department of Sensory and Motor Organs, School of Medicine, Faculty of Medicine, Tottori University | |||||
| 著者ID | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | 04942 | |||||
| 著者ID | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | 00271 | |||||
| 著者ID | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | 00405 | |||||
| 著者ID | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | 00369 | |||||
| 抄録 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | Background: Chemotherapy-induced nausea and vomiting (CINV) are the most common and distressing adverse events in patients receiving anticancer therapy. Radiotherapy also induces nausea and vomiting, so concurrent chemoradiotherapy-induced nausea and vomiting (CRINV) are significant problems for patients undergoing chemoradiotherapy. Conventionally, three-drug combination therapy with dexamethasone, 5-hydroxytryptamine type 3 (5-HT3) receptor antagonist, and neurokinin-1 (NK1) receptor antagonist has been used to prevent CRINV induced by concurrent chemoradiotherapy with cisplatin for patients with head and neck cancer (HNC). Nonetheless, CRINV still remains a problem. The effectiveness of adding olanzapine to prevent CINV has been reported, suggesting the efficacy of four-drug combination therapy for CRINV. However, its effectiveness has hardly been reported in patient receiving chemoradiotherapy for HNC. Methods: A total of 109 patients with HNC who received concurrent chemoradiotherapy with cisplatin from April 2014 to March 2021 were included and divided into the following two groups according to antiemetic treatment regimen: the conventional group (Con group; n = 78) who received three-drug combination therapy and the olanzapine group (Olz group; Olz group, n = 31) who received four-drug combination therapy with olanzapine. Acute (0 to 24 h from cisplatin) and delayed (25 to 120 h from cisplatin) CRINV were then compared using the Common Terminology Criteria for Adverse Events. Results: No significant difference in acute CRINV were observed between both groups (P = 0.5761, Fisher’s exact test). However, the Olz group had a significantly lower incidence rate of delayed CRINV over Grade 3 compared to the Con group (P = 0.0318, Fisher’s exact test). Conclusion: Four-drug combination therapy with olanzapine was effective in suppressing delayed CRINV due to chemoradiotherapy with cisplatin for HNC. | |||||
| 書誌情報 |
Yonago Acta Medica en : Yonago Acta Medica 巻 66, 号 2, p. 208-213, 発行日 2023-05-25 |
|||||
| 出版者 | ||||||
| 出版者 | Tottori University Medical Press | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 05135710 | |||||
| 書誌レコードID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AA00892882 | |||||
| DOI | ||||||
| 関連タイプ | isIdenticalTo | |||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | 10.33160/yam.2023.05.002 | |||||
| 権利 | ||||||
| 権利情報 | (C) 2023 Tottori University Medical Press. | |||||
| 情報源 | ||||||
| 関連名称 | Yonago Acta Medica. 2023, 66(2), 208-213. doi10.33160/yam.2023.05.002 | |||||
| 関連サイト | ||||||
| 識別子タイプ | URI | |||||
| 関連識別子 | https://www.lib.tottori-u.ac.jp/yam/yam/yam66-2/66-2contents.html | |||||
| 関連名称 | https://www.lib.tottori-u.ac.jp/yam/yam/yam66-2/66-2contents.html | |||||
| 関連サイト | ||||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | https://doi.org/10.33160/yam.2023.05.002 | |||||
| 関連名称 | https://doi.org/10.33160/yam.2023.05.002 | |||||
| 著者版フラグ | ||||||
| 出版タイプ | VoR | |||||
| EISSN | ||||||
| 値 | 13468049 | |||||
